Compositions and methods for the inhibition of phospholipase A2
Details for Australian Patent Application No. 2006331355 (hide)
International Classifications
Event Publications
24 July 2008 PCT application entered the National Phase
PCT publication WO2007/074169 Priority application(s): WO2007/074169
11 September 2008 Amendment Made
The nature of the amendment is: Amend the priority details to include 11/644,625 22 Dec 2006 US 2006331356 Immupharma France SA The nature of the amendment is: Amend the name of the co-inventors to read Guichard, Gilles and Lena, Gersande
13 August 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Jun 2009 2007
29 September 2011 Application Accepted
Published as AU-B-2006331355
2 February 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006331356-Compositions and methods for the treatment and prevention of disease
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser